Literature DB >> 26190624

In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein Formulations.

Carly Fleagle Chisholm1, Bao Han Nguyen1, Kaitlin R Soucie1, Raul M Torres2, John F Carpenter3, Theodore W Randolph4.   

Abstract

Subvisible particles in a therapeutic protein product may act as adjuvants to promote unwanted immune responses against the protein. Silicone oil is used as a lubricant in prefilled syringes, and microdroplets of silicone oil are often detected in protein formulations expelled from prefilled syringes. In order to test the adjuvant potency of silicone oil microdroplets, antibody responses in mice to subcutaneous injections of formulations of ovalbumin (OVA) that contained silicone oil microdroplets were measured. These responses were compared against responses to oil-free OVA formulations and to OVA formulations that contained microparticulate aluminum hydroxide ("alum"), the common vaccine adjuvant. When administered with high concentrations of silicone oil microdroplets, OVA formulations elicited strong anti-OVA IgG1 and IgG2a antibody responses. These responses were equivalent to those observed when alum microparticles were added to OVA formulations, suggesting that silicone oil can act as a potent adjuvant. However, when OVA formulations were prepared with lower levels of silicone oil that had been obtained directly from commercial siliconized syringes, the anti-OVA antibody response was not enhanced significantly compared with responses against OVA alone.
© 2015 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  adjuvant effect; immune response; immunology; particle size; prefilled syringes; protein aggregation; protein formulation; protein structure; silicone oil; subvisible particles

Mesh:

Substances:

Year:  2015        PMID: 26190624      PMCID: PMC4604024          DOI: 10.1002/jps.24573

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  52 in total

1.  THE ANTIGENICITY OF AGGREGATED AND AGGREGATE-FREE HUMAN GAMMA-GLOBULIN FOR RABBITS.

Authors:  C E BIRO; G GARCIA
Journal:  Immunology       Date:  1965-04       Impact factor: 7.397

2.  Studies of aggregated gamma-globulin. II. Effect in vivo.

Authors:  C L CHRISTIAN
Journal:  J Immunol       Date:  1960-01       Impact factor: 5.422

3.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

4.  An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen.

Authors:  Aaron Patton; Michael C Mullenix; Steven J Swanson; Eugen Koren
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

5.  A statistically defined endpoint titer determination method for immunoassays.

Authors:  A Frey; J Di Canzio; D Zurakowski
Journal:  J Immunol Methods       Date:  1998-12-01       Impact factor: 2.303

6.  Factor VIII inhibitors: a continuing problem.

Authors:  L W Hoyer
Journal:  J Lab Clin Med       Date:  1993-03

Review 7.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

Authors:  J L Cleland; M F Powell; S J Shire
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1993       Impact factor: 4.889

8.  Silicone oil induced aggregation of proteins.

Authors:  Latoya S Jones; Allyn Kaufmann; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2005-04       Impact factor: 3.534

9.  The adjuvant effect of silicone-gel on antibody formation in rats.

Authors:  J O Naim; R J Lanzafame; C J van Oss
Journal:  Immunol Invest       Date:  1993-03       Impact factor: 3.657

10.  Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens.

Authors:  C M Snapper; T M McIntyre; R Mandler; L M Pecanha; F D Finkelman; A Lees; J J Mond
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  8 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

2.  Differences in the incidence of aflibercept-related sterile endophthalmitis according to types of disposable syringes used.

Authors:  Minjeong Kim; Jee Taek Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-02       Impact factor: 3.117

3.  Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.

Authors:  Carly Fleagle Chisholm; Taek Jin Kang; Miao Dong; Kasey Lewis; Madhuri Namekar; Axel T Lehrer; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2019-01-28       Impact factor: 5.571

4.  Silicone Oil Microdroplets Can Induce Antibody Responses Against Recombinant Murine Growth Hormone in Mice.

Authors:  Carly Fleagle Chisholm; Abby E Baker; Kaitlin R Soucie; Raul M Torres; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2016-03-25       Impact factor: 3.534

Review 5.  Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.

Authors:  Wim Jiskoot; Grzegorz Kijanka; Theodore W Randolph; John F Carpenter; Atanas V Koulov; Hanns-Christian Mahler; Marisa K Joubert; Vibha Jawa; Linda O Narhi
Journal:  J Pharm Sci       Date:  2016-04-01       Impact factor: 3.534

Review 6.  Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review.

Authors:  William J Anderson; Natasha Ferreira Santos da Cruz; Luiz Henrique Lima; Geoffrey G Emerson; Eduardo Büchele Rodrigues; Gustavo Barreto Melo
Journal:  Int J Retina Vitreous       Date:  2021-05-07

7.  Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.

Authors:  Oswald Moling; Andrea Piccin; Martina Tauber; Peter Marinello; Mariagrazia Canova; Marco Casini; Giovanni Negri; Bernd Raffeiner; Raffaella Binazzi; Latha Gandini; Cinzia Vecchiato; Giovanni Rimenti; Atto Billio
Journal:  J Med Case Rep       Date:  2016-09-15

8.  Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial.

Authors:  Natasha Ferreira Santos da Cruz; Murilo Ubukata Polizelli; Felipe Picanço Muralha; Clarice Neuenschwander Lins de Morais; Octaviano Magalhães Silva Junior; Mauricio Maia; Gustavo Barreto Melo; Michel Eid Farah
Journal:  Int J Retina Vitreous       Date:  2022-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.